Ladenburg Thalmann Downgrades Genetic Technologies (GENE) to Sell
Tweet
Share
E-mailGet Alerts GENE Hot Sheet
Price: $2.18 -3.11%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Ladenburg Thalmann downgraded Genetic Technologies (NASDAQ: GENE) from Buy to Sell with a price target of $1.60 (from $7.50).
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.18 yesterday.
For an analyst ratings summary and ratings history on Genetic Technologies click here. For more ratings news on Genetic Technologies click here.
Shares of Genetic Technologies closed at $3.18 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Monster Beverage (MNST) to Neutral, 'Cost Pressures and Weaker Low-end Consumer'
- Truist Securities Double Downgrades Monster Beverage (MNST) to Sell
- Truist Securities Downgrades HashiCorp Inc (HCP) to Hold
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
